Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Asia Virtual Congress 2020

New treatment paradigms in the treatment of locoregionally advanced nasopharyngeal cancer

Optimizing therapeutic effect of concurrent chemotherapy by incorporating immunotherapy for locoregionally advanced NPC: Recent developments and biomarkers

Date

22 Nov 2020

Session

New treatment paradigms in the treatment of locoregionally advanced nasopharyngeal cancer

Topics

Cytotoxic Therapy;  Immunotherapy

Tumour Site

Head and Neck Cancers

Presenters

Brigette Ma

Authors

B.B.Y. Ma

Author affiliations

  • Clinical Oncology Department, Prince Of Wales Hospital, Basement, Lks Special, The Chinese University of Hong Kong, 0000 - Sha Tin/HK

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Login

Resources from the same session

LIVE Q&A

Presenter: Amanda Psyrri

Session: New treatment paradigms in the treatment of locoregionally advanced nasopharyngeal cancer

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.